| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 02/20/2003 | WO2003014090A1 Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 02/20/2003 | WO2003014082A1 Cyclopenta ` b ! indole derivatives as spla2 inhibitors |
| 02/20/2003 | WO2003014077A2 Crystal forms and mutants of rank ligand |
| 02/20/2003 | WO2003013545A1 Novel benzo-fused heterocycles as endothelin antagonisits |
| 02/20/2003 | WO2003013530A2 Salts of substituted 1, 2, 3, 4-tetrahydroquinoline-2-carboxylic acid derivatives as nmda antagonists |
| 02/20/2003 | WO2003013523A1 Sh3 protein domains and their ligands |
| 02/20/2003 | WO2003013518A1 Alpha-ketoamide derivatives as cathepsin k inhibitors |
| 02/20/2003 | WO2003013517A1 Aminoisoxazole derivatives active as kinase inhibitors |
| 02/20/2003 | WO2003013513A1 Stable emulsion composition |
| 02/20/2003 | WO2003013494A1 Remedial agent for arthrosis deformans |
| 02/20/2003 | WO2003013493A1 Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs |
| 02/20/2003 | WO2003013440A2 Treatment and prevention of heat shock protein-associated diseases and conditions |
| 02/20/2003 | WO2003013436A2 Kavalactone compositions and methods of use |
| 02/20/2003 | WO2003013434A2 Methods and compositions for treating diseases associated with excesses in ace |
| 02/20/2003 | WO2003013427A2 A method for preparing fluticasone derivatives |
| 02/20/2003 | WO2003013420A2 Isoprenyl derivatives and their use in the treatment and prevention of osteoporosis and cardiovascular calcification |
| 02/20/2003 | WO2002096927A3 Ribozyme based treatment of female reproductive diseases |
| 02/20/2003 | WO2002085368A3 Use of radical scavenging compounds for treatment and prevention of no-dependent microcirculation disorders |
| 02/20/2003 | WO2002083733A3 Polynucleotides and polypeptides of the ifnalpha-6 gene |
| 02/20/2003 | WO2002072003A3 Use of steroid derivatives for the treatment of a benighn and/or malignant tumour |
| 02/20/2003 | WO2002064126A3 Method of treating of demyelinating diseases or conditions |
| 02/20/2003 | WO2002049993A3 High affinity small molecule c5a receptor modulators |
| 02/20/2003 | WO2002042295A3 Peptides as met-ap2 inhibitors |
| 02/20/2003 | WO2002029088A9 Highly expressible genes |
| 02/20/2003 | WO2002022621B1 INTERPHENYLENE 7-OXABICYCLIC[2.2.1]HEPTANE OXAZOLES AS PROSTAGLANDIN F2a ANTAGONISTS |
| 02/20/2003 | US20030036801 Cartilage repair apparatus and method |
| 02/20/2003 | US20030036568 Permeation enhancers |
| 02/20/2003 | US20030036552 Novel compounds |
| 02/20/2003 | US20030036543 Especially as inhibitors of Aurora-2 and GSK-3, for treating diseases such as cancer, diabetes and Alzheimer's disease. |
| 02/20/2003 | US20030036184 Polypeptides exhibiting PDE7 activity and their use for selecting compounds which inhibit PDE 7 enzyme activity |
| 02/20/2003 | US20030036075 Nucleotide sequences coding transport protein for us in the treatment and diagnosis of cancer, arthritis, vision defects and skin dsorders |
| 02/20/2003 | CA2457622A1 Kavalactone compositions and methods of use |
| 02/20/2003 | CA2456965A1 A medicine for osteoarthritis |
| 02/20/2003 | CA2456762A1 Interleukin-1 receptors in the treatment of diseases |
| 02/20/2003 | CA2456708A1 Crystal forms and mutants of rank ligand |
| 02/20/2003 | CA2456607A1 Uses of mammalian cytokine; related reagents |
| 02/20/2003 | CA2456533A1 Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs |
| 02/20/2003 | CA2456291A1 Hydroxamic acid derivatives |
| 02/20/2003 | CA2456287A1 Anti-idiotypic antibodies of hla class i molecules and the use thereof in the preparation of compositions that are designed to inhibit vascular activation |
| 02/20/2003 | CA2456124A1 Substituted 5,6,6a,11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid derivatives serving as nmda antagonists |
| 02/20/2003 | CA2456103A1 Salts of substituted 1, 2, 3, 4-tetrahydroquinoline-2-carboxylic acid derivatives |
| 02/20/2003 | CA2455759A1 Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 02/20/2003 | CA2455631A1 Aminoisoxazole derivatives active as kinase inhibitors |
| 02/20/2003 | CA2454417A1 Novel benzo-fused heterocycles as endothelin antagonists |
| 02/20/2003 | CA2453995A1 Tacis and br3 polypeptides and uses thereof |
| 02/19/2003 | WO2002016574A2 Method for identifying peptides that can be specifically cleaved and the use of peptide sequences of this type |
| 02/19/2003 | EP1284265A1 Benzothiophene derivatives and medicinal use thereof |
| 02/19/2003 | EP1283886A2 Intracellular signaling proteins |
| 02/19/2003 | EP1283851A2 Use of interleukin-4 antagonists and compositions thereof |
| 02/19/2003 | EP1283835A2 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as protein kinase modulators |
| 02/19/2003 | EP1283834A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 02/19/2003 | EP1283833A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 02/19/2003 | EP1283832A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 02/19/2003 | EP1283831A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 02/19/2003 | EP1283827A2 Caspase inhibitors and uses thereof |
| 02/19/2003 | EP1283825A1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors |
| 02/19/2003 | EP1283823A1 Novel mmp-2/mmp-9 inhibitors |
| 02/19/2003 | EP1283735A2 Method for the improvement of islet signaling in diabetes mellitus and for its prevention |
| 02/19/2003 | EP1283723A2 Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor |
| 02/19/2003 | EP1283721A1 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders |
| 02/19/2003 | EP1283715A1 Modulaton of alpha-6 integrin-mediated responses |
| 02/19/2003 | EP1133491B1 Novel benzofurane derivatives, preparation method, use as medicines and pharmaceutical compositions containing same |
| 02/19/2003 | EP1131327B1 Prostaglandin conjugates for treating or preventing bone diseases |
| 02/19/2003 | EP0950065B1 Peptide as diagnostic and therapeutic agent for autoimmune diseases |
| 02/19/2003 | CN1398264A 吲哚－3－基衍生物 Indol-3-yl derivative |
| 02/19/2003 | CN1398260A 二肽腈组织蛋白酶k抑制剂 Dipeptide nitrile cathepsin inhibitors k |
| 02/19/2003 | CN1397333A Capsule for treating cervical spondylopathy and its preparing process |
| 02/19/2003 | CN1397325A Powdered medicine for quickly treating bone fracture and injury and its preparing process |
| 02/19/2003 | CN1397322A Chinese medicine for treating gout and process for preparing its instant particles |
| 02/19/2003 | CN1397290A Chiense medicine for treating one fracture |
| 02/19/2003 | CN1397287A Capsule for treating lumbocrural pain |
| 02/19/2003 | CN1101816C Substituted purine derivatives, processes for their prepn. their use, and compsns. comprising them |
| 02/19/2003 | CN1101807C 异羟肟酸衍生物 Hydroxamic acid derivatives |
| 02/19/2003 | CN1101697C Externally applied Chinese medicine for treating bone fracture and prepn. method thereof |
| 02/19/2003 | CN1101695C Application of medicine from plant extracts for treatment of increase bone resorption, and compsns, thereof |
| 02/19/2003 | CN1101693C Externally applied Chinese medicine |
| 02/19/2003 | CA2420065A1 Methods for indentifying specifically cleavable peptides and use of such peptide sequences |
| 02/18/2003 | WO2002016329A1 Novel phenylalanine derivatives |
| 02/18/2003 | US6521759 Aminothiazole inhibitors of cyclin dependent kinases |
| 02/18/2003 | US6521750 Nucleotide sequence coding human protein for use in treatment of osteoporosis and bone disorders |
| 02/18/2003 | US6521667 Calcilytic compounds |
| 02/18/2003 | US6521655 Substituted imidazoles useful in the treatment of inflammatory diseases |
| 02/18/2003 | US6521654 Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations including them |
| 02/18/2003 | US6521646 Integrin inhibitors |
| 02/18/2003 | US6521643 Pyridine compounds and their pharmaceutical use |
| 02/18/2003 | US6521640 Method for interviewing neuronal death using sulfasalazine |
| 02/18/2003 | US6521606 Matrix metalloproteinase inhibitors |
| 02/18/2003 | US6521422 Fhm, a novel member of the TNF ligand supergene family |
| 02/18/2003 | US6521248 Cavitation; reduced pressure; oxygenated water |
| 02/18/2003 | CA2420042A1 Carboxylic acid derivatives, processes for the preparation thereof and pharmaceutical agents comprising the same as active ingredient |
| 02/18/2003 | CA2085750C Osteoinductive pharmaceutical formulations |
| 02/15/2003 | CA2392309A1 Neuropeptide receptor and uses thereof |
| 02/14/2003 | WO2002018326A1 Novel propenohydroxamic acid derivatives |
| 02/14/2003 | CA2423733A1 Novel propenohydroxamic acid derivatives |
| 02/13/2003 | WO2003012441A1 Method for detecting modulators of notch signalling |
| 02/13/2003 | WO2003012122A2 Crystallized structure of type iv collagen nc1 domain hexamer |
| 02/13/2003 | WO2003012111A2 Conjugates for the modulation of immune responses |
| 02/13/2003 | WO2003012105A2 Vegf isoform |
| 02/13/2003 | WO2003011895A2 Compositions and methods for modulation of immune responses |
| 02/13/2003 | WO2003011892A2 Glp-1 exendin-4 peptide analogs and uses thereof |